These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 34863974)
1. Synthesis and Evaluation of High Functionality and Quality Cell-penetrating Peptide Conjugated Lipid for Octaarginine Modified PEGylated Liposomes In U251 and U87 Glioma Cells. El-Gamal FR; Akl MA; Mowafy HA; Mukai H; Kawakami S; Afouna MI J Pharm Sci; 2022 Jun; 111(6):1719-1727. PubMed ID: 34863974 [TBL] [Abstract][Full Text] [Related]
2. Development of High-Functionality and -Quality Lipids with RGD Peptide Ligands: Application for PEGylated Liposomes and Analysis of Intratumoral Distribution in a Murine Colon Cancer Model. Suga T; Kato N; Hagimori M; Fuchigami Y; Kuroda N; Kodama Y; Sasaki H; Kawakami S Mol Pharm; 2018 Oct; 15(10):4481-4490. PubMed ID: 30179010 [TBL] [Abstract][Full Text] [Related]
4. Ligand peptide-grafted PEGylated liposomes using HER2 targeted peptide-lipid derivatives for targeted delivery in breast cancer cells: The effect of serine-glycine repeated peptides as a spacer. Suga T; Fuchigami Y; Hagimori M; Kawakami S Int J Pharm; 2017 Apr; 521(1-2):361-364. PubMed ID: 28237886 [TBL] [Abstract][Full Text] [Related]
5. Microfluidic Post-Insertion Method for the Efficient Preparation of PEGylated Liposomes Using High Functionality and Quality Lipids. Sugimoto Y; Suga T; Kato N; Umino M; Yamayoshi A; Mukai H; Kawakami S Int J Nanomedicine; 2022; 17():6675-6686. PubMed ID: 36597433 [TBL] [Abstract][Full Text] [Related]
6. Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery. Kibria G; Hatakeyama H; Ohga N; Hida K; Harashima H J Control Release; 2011 Jul; 153(2):141-8. PubMed ID: 21447361 [TBL] [Abstract][Full Text] [Related]
7. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer. Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357 [TBL] [Abstract][Full Text] [Related]
8. Cell-penetrating Peptide-coated Liposomes for Drug Delivery Across the Blood-Brain Barrier. Yuan BO; Zhao Y; Dong S; Sun Y; Hao F; Xie J; Teng L; Lee RJ; Fu Y; Bi YE Anticancer Res; 2019 Jan; 39(1):237-243. PubMed ID: 30591464 [TBL] [Abstract][Full Text] [Related]
9. Development of an apolipoprotein E mimetic peptide-lipid conjugate for efficient brain delivery of liposomes. Kato N; Yamada S; Suzuki R; Iida Y; Matsumoto M; Fumoto S; Arima H; Mukai H; Kawakami S Drug Deliv; 2023 Dec; 30(1):2173333. PubMed ID: 36718920 [TBL] [Abstract][Full Text] [Related]
10. A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system. Kibria G; Hatakeyama H; Harashima H Int J Pharm; 2011 Jun; 412(1-2):106-14. PubMed ID: 21414394 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of a novel adapter lipid derivative for preparation of cyclic peptide-modified PEGylated liposomes: Application of cyclic RGD peptide. Kato N; Sato T; Fuchigami Y; Suga T; Geng L; Tsurumaru M; Hagimori M; Mukai H; Kawakami S Eur J Pharm Sci; 2022 Sep; 176():106239. PubMed ID: 35714942 [TBL] [Abstract][Full Text] [Related]
12. [The construction of cell-penetrating peptide R8 and pH sensitive cleavable polyethylene glycols co-modified liposomes]. Zhang L; Wang Y; Gao HL; He Q Yao Xue Xue Bao; 2015 Jun; 50(6):760-6. PubMed ID: 26521450 [TBL] [Abstract][Full Text] [Related]
13. Stearylated INF7 peptide enhances endosomal escape and gene expression of PEGylated nanoparticles both in vitro and in vivo. El-Sayed A; Masuda T; Akita H; Harashima H J Pharm Sci; 2012 Feb; 101(2):879-82. PubMed ID: 22086751 [TBL] [Abstract][Full Text] [Related]
14. Dual Receptor Recognizing Cell Penetrating Peptide for Selective Targeting, Efficient Intratumoral Diffusion and Synthesized Anti-Glioma Therapy. Liu Y; Mei L; Xu C; Yu Q; Shi K; Zhang L; Wang Y; Zhang Q; Gao H; Zhang Z; He Q Theranostics; 2016; 6(2):177-91. PubMed ID: 26877777 [TBL] [Abstract][Full Text] [Related]
15. Cell-Penetrating Peptide and Transferrin Co-Modified Liposomes for Targeted Therapy of Glioma. Wang X; Zhao Y; Dong S; Lee RJ; Yang D; Zhang H; Teng L Molecules; 2019 Sep; 24(19):. PubMed ID: 31574945 [TBL] [Abstract][Full Text] [Related]
16. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting. Liu Y; Ran R; Chen J; Kuang Q; Tang J; Mei L; Zhang Q; Gao H; Zhang Z; He Q Biomaterials; 2014 Jun; 35(17):4835-47. PubMed ID: 24651033 [TBL] [Abstract][Full Text] [Related]
17. [Cell penetrating peptides enhance intracellular translocation and function of siRNA encapsulated in Pegylated liposomes]. Wang W; Tang N; Zhang CL; Liu XJ; Hu H; Zhang ZX; Liang W Yao Xue Xue Bao; 2006 Feb; 41(2):142-8. PubMed ID: 16671545 [TBL] [Abstract][Full Text] [Related]
18. Development of Triple-Negative Breast Cancer-Targeted Liposomes with MUC16 Binding Peptide Ligand in Triple-Negative Breast Cancer Cells. Hagimori M; Kato N; Orimoto A; Suga T; Kawakami S J Pharm Sci; 2023 Jun; 112(6):1740-1745. PubMed ID: 36878391 [TBL] [Abstract][Full Text] [Related]
19. An efficient PEGylated gene delivery system with improved targeting: Synergism between octaarginine and a fusogenic peptide. Khalil IA; Harashima H Int J Pharm; 2018 Mar; 538(1-2):179-187. PubMed ID: 29341911 [TBL] [Abstract][Full Text] [Related]
20. Effect of PEG pairing on the efficiency of cancer-targeting liposomes. Saw PE; Park J; Lee E; Ahn S; Lee J; Kim H; Kim J; Choi M; Farokhzad OC; Jon S Theranostics; 2015; 5(7):746-54. PubMed ID: 25897339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]